The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Cannabis Use and Psychosis: A Longitudinal Population-based Study
Abstract
Cannabis use may increase the risk of psychotic disorders and result in a poor prognosis for those with an established vulnerability to psychosis. A 3-year follow-up (1997-1999) is reported of a general population of 4,045 psychosis-free persons and of 59 subjects in the Netherlands with a baseline diagnosis of psychotic disorder. Substance use was assessed at baseline, 1-year follow-up, and 3-year follow-up. Baseline cannabis use predicted the presence at follow-up of any level of psychotic symptoms (adjusted odds ratio (OR) = 2.76, 95% confidence interval (CI): 1.18, 6.47), as well as a severe level of psychotic symptoms (OR = 24.17, 95% CI: 5.44, 107.46), and clinician assessment of the need for care for psychotic symptoms (OR = 12.01, 95% CI: 2.24, 64.34). The effect of baseline cannabis use was stronger than the effect at 1-year and 3-year follow-up, and more than 50% of the psychosis diagnoses could be attributed to cannabis use. On the additive scale, the effect of cannabis use was much stronger in those with a baseline diagnosis of psychotic disorder (risk difference, 54.7%) than in those without (risk difference, 2.2%; p for interaction = 0.001). Results confirm previous suggestions that cannabis use increases the risk of both the incidence of psychosis in psychosis-free persons and a poor prognosis for those with an established vulnerability to psychotic disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is evidence to suggest a positive association between cannabis use and development of psychosis, in people susceptible to psychotic disorders.117–119”
From Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions (2024) · cites this paper as [117]
In the citing paper
“In the Dutch NEMESIS study (14) cumulative cannabis use was associated with incident psychotic outcomes measured 3 years later (OR 1.89, 95% CI 1.25, 2.85).”
From Association Between Cannabis and Psychosis: Epidemiologic Evidence (2016) · cites this paper as [14]
In the citing paper
“Whilst the CHDS, NEMESIS and ALSPAC studies all attempted to model for attrition, and found no evidence that this impacted on the findings (14,17,23), these methods rely on a number of assumptions, and bias cannot be entirely excluded.”
From Association Between Cannabis and Psychosis: Epidemiologic Evidence (2016) · cites this paper as [14]
In the citing paper
“For example, a number of studies (12)(13)(14), although not all (16,23) found evidence for specificity of exposure, namely that associations between other drug use and psychosis are weaker than for cannabis.”
From Association Between Cannabis and Psychosis: Epidemiologic Evidence (2016) · cites this paper as [14]
In the citing paper
“| NEMESIS | 4045 | Ever use | Psychosis | 2.76 | Legality of | Sample |”
From Association Between Cannabis and Psychosis: Epidemiologic Evidence (2016) · cites this paper as [14]
Citations
Cites
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,285
The Structured Clinical Interview for DSM-III-R (SCID): I: History, Rationale, and Description
Spitzer, R. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080032005 · Cited by 4,336
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Kessler, R. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830160031005 · Cited by 2,085
Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R)
Spitzer, R. L., & Williams, J. (1987) · Cited by 1,823
- Statistical Models for Epidemiology
(2013) · Bayesian Methods in Epidemiology · doi:10.1201/b15382-9 · Cited by 1,346
Bijl, R. V., Ravelli, A., & van Zessen, G. (1998) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050098 · Cited by 1,216 · cited 2×
“Subjects were contacted three times: in 1996 (baseline), in 1997 (T1—assessing the period between baseline and T1), and in 1999 (T2—assessing the period between T1 and T2) (14, 15).”
BackgroundCannabis and schizophrenia. A longitudinal study of Swedish conscripts
Andréasson, S., Engström, A., Allebeck, P., & Rydberg, U. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92620-1 · Cited by 1,166
Tanda, G., Pontieri, F. E., & Chiara, G. D. (1997) · Science · doi:10.1126/science.276.5321.2048 · Cited by 1,080
Strauss (1969) revisited: a psychosis continuum in the general population?
van Os, J., Hanssen, M., Bijl, R. V., & Ravelli, A. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00224-8 · Cited by 893
Self-citationCannabis Abuse and the Course of Recent-Onset Schizophrenic Disorders
Linszen, D. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040017002 · Cited by 656
Helzer, J. E. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790300019003 · Cited by 617
van Os, J., Hanssen, M., Bijl, R. V., & Vollebergh, W. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.7.663 · Cited by 564
Self-citationAnthony, J. C. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790300029004 · Cited by 558
What is a Cause and How Do We Know One? A Grammar for Pragmatic Epidemiology
Susser, M. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115939 · Cited by 531
Alcohol and drug use in UK university students
Webb, E., Ashton, C., Kelly, P., & Kamali, F. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03410-1 · Cited by 472
Psychiatric effects of cannabis
Johns, A. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.2.116 · Cited by 469
Elevated endogenous cannabinoids in schizophrenia
Leweke, F. M., Giuffrida, A., Wurster, U., Emrich, H. M., & Piomelli, D. (1999) · NeuroReport · doi:10.1097/00001756-199906030-00008 · Cited by 432
Dean, B., Sundram, S., Bradbury, R., Scarr, E., & Copolov, D. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00552-2 · Cited by 383
The Netherlands Mental Health Survey and Incidence Study (NEMESIS): objectives and design
Bijl, R. V., van Zessen, G., Ravelli, A., de Rijk, C., & Langendoen, Y. (1998) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050097 · Cited by 371
Graaf, R. D., Bijl, R. V., Smit, F., Ravelli, A., & Vollebergh, W. A. M. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.11.1039 · Cited by 355
Substance abuse and the onset of schizophrenia
Hambrecht, M., & Häfner, H. (1996) · Biological Psychiatry · doi:10.1016/s0006-3223(95)00609-5 · Cited by 339
Eaton, W. W., Neufeld, K., Chen, L.-S., & Cai, G. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.217 · Cited by 339 · cited 1×
“Interviewers read the questions and record respondents’ answers, making the CIDI essentially a self-report instrument (17).”
BackgroundSlade, M., Phelan, M., Thornicroft, G., & Parkman, S. (1996) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00785756 · Cited by 236
Cannabis and Psychosis: Is there Epidemiological Evidence for an Association?
Thornicroft, G. (1990) · British Journal of Psychiatry · doi:10.1192/bjp.157.1.25 · Cited by 235
Andréasson, S., Allebeck, P., Engström, A., & Rydberg, U. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91823-5 · Cited by 202
DEGENHARDT, L., & HALL, W. (2001) · Psychological Medicine · doi:10.1017/s0033291701003865 · Cited by 193
Diagnosis and Need for Treatment Are Not the Same
Spitzer, R. L. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.2.120 · Cited by 193
Substance Use Disorder and the Early Course of Illness in Schizophrenia and Affective Psychosis
Kovasznay, B., Fleischer, J., Tanenberg-Karant, M., Jandorf, L., Miller, A. D., & Bromet, E. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.2.195 · Cited by 177
Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis
McGuire, P. K., Jones, P., Harvey, I., Williams, M., McGuffin, P., & Murray, R. M. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(94)00053-b · Cited by 165
Drug use and drinking among students in 36 countries
Smart, R. G., & Ogborne, A. C. (2000) · Addictive Behaviors · doi:10.1016/s0306-4603(99)00013-1 · Cited by 160
Biologic Synergism and Parallelism
Darroch, J. N. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009164 · Cited by 140
Gorriti, M. Á., de Fonseca, F. R., Navarro, M., & Palomo, T. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00851-6 · Cited by 137
Perkonigg, A., Lieb, R., Höfler, M., Schuster, P. M., Sonntag, H., & Wïttchen, H. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.941116635.x · Cited by 137
The ecogenetics of schizophrenia: a review
van Os, J., & Marcelis, M. C. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00049-8 · Cited by 107
Cannabis Consumption as a Prognostic Factor in Schizophrenia
Mj, M., Calcedo-Ordonez, A., & Varo-Prieto, J. R. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.164.5.679 · Cited by 93
Suicidality and substance misuse in first-admitted subjects with psychotic disorder
Verdoux, H., Liraud, F., Gonzalès, B., Assens, F., Abalan, F., & van Os, J. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1999.tb10883.x · Cited by 78
RELAPSE OF DEPRESSION IN PEOPLE WITH DOWN'S SYNDROME
Cooper, S., & Collacott, R. A. (1994) · The British Journal of Mental Subnormality · doi:10.1179/bjdd.1994.005 · Cited by 15
Cited by
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
The environment and schizophrenia
van Os, J., Kenis, G., & Rutten, B. P. F. (2010) · Nature · doi:10.1038/nature09563 · Cited by 1,572
Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.026 · Cited by 1,409
Linscott, R. J., & van Os, J. (2013) · Psychological Medicine · doi:10.1017/s0033291712001626 · Cited by 1,181
Adverse health effects of non-medical cannabis use
Hall, W., & Degenhardt, L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61037-0 · Cited by 1,134
Metadata
- Authors
- van Os, J.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-08-15
- Volume
- 156
- Issue
- 4
- Pages
- 319-327
- ISSN
- 0002-9262 (ISSN-L)
- OpenAlex
- W2122251240
- Cited by
- 928
- References
- 39
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 13 · 2023: 21 · 2022: 22 · 2021: 31 · 2020: 32 · 2019: 40 · 2018: 31 · 2017: 31 · 2016: 41 · 2015: 47 · 2014: 41 · 2013: 46 · 2012: 46
- FWCI
- 24.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- cannabis use, psychosis, psychotic symptoms, psychosis risk, substance use, prognosis, general population
- MeSH terms
- Adolescent, Adult, Female, Humans, Longitudinal Studies, Male, Marijuana Smoking, Middle Aged, Netherlands, Prognosis, Psychotic Disorders, Risk Factors, Incidence, Odds Ratio
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.